RedHill Biopharma (RDHL) Non-Current Assets (2012 - 2026)
RedHill Biopharma (RDHL) posted Non-Current Assets of $17.7 million for the quarter ended Jun 30, 2026, up 204.1% from $5.82 million a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Non-Current Assets (2012 - 2026) Analysis & Trends
As of Dec 31, 2025, RedHill Biopharma's Non-Current Assets came in at $18.82 million, up 206.9% from the prior year.
- Annual Non-Current Assets shows a five-year compound annual growth rate of -29.7% (years ended Dec 2020 to Dec 2025).
- In prior years, RedHill Biopharma's Non-Current Assets was $6.13 million in the year ended Dec 31, 2024 (-11.2%), $6.91 million in the year ended Dec 31, 2023 (-90.5%), $72.97 million in the year ended Dec 31, 2022 (-20.7%) and $92.04 million in the year ended Dec 31, 2021 (-16.1%).
- Quarterly Non-Current Assets has run from a low of $5.82 million in the quarter ended Jun 30, 2025 to a high of $92.04 million in the quarter ended Dec 31, 2021 over five years.
- On a year-over-year basis, Non-Current Assets increased in two of the last four quarters, with growth averaging 98.0%.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was the quarter ended Dec 31, 2025, with growth of 206.9%; the weakest was the quarter ended Dec 31, 2023, with a decline of 90.5%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 159.77 Bn |
| 10 | RedHill Biopharma | 1.44 Mn | -15.18 Mn | - | 17.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.70 Mn |
| Dec 31, 2025 | 18.82 Mn |
| Jun 30, 2025 | 5.82 Mn |
| Dec 31, 2024 | 6.13 Mn |
| Jun 30, 2024 | 6.32 Mn |
| Dec 31, 2023 | 6.91 Mn |
| Jun 30, 2023 | 7.99 Mn |
| Dec 31, 2022 | 72.97 Mn |
| Jun 30, 2022 | 76.70 Mn |
| Dec 31, 2021 | 92.04 Mn |
| Jun 30, 2021 | 105.18 Mn |
| Dec 31, 2020 | 109.75 Mn |
| Jun 30, 2020 | 105.24 Mn |
| Dec 31, 2019 | 20.89 Mn |
| Jun 30, 2019 | 9.72 Mn |
| Dec 31, 2018 | 5.62 Mn |
| Jun 30, 2018 | 5.63 Mn |
| Mar 31, 2018 | 5.66 Mn |
| Dec 31, 2017 | 5.67 Mn |
| Dec 31, 2016 | 6.40 Mn |
API Access
RedHill Biopharma Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();